News
A panelist discusses how real-world data presented at the 2025 American Academy of Dermatology Annual Meeting (AAD 2025) demonstrates that initiating ruxolitinib cream therapy for atopic dermatitis ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback